The World Health Organisation (WHO) named Omicron a variant of concern on the 26th November 2021 as its mutation may impact how it behaves. One of the main concerns is the number of mutations on the spike protein, which is the part of the virus that binds to human cells. Currently, research worldwide is being conducted to understand the variant better. More information on the variant is expected in the coming weeks.
Beijing Lepu Medical Technology will continue to follow up of the mutations of Covid-19, perform sequence alignment analysis and evaluate and verify the detection ability of key mutation sites to ensure the sensitivity and specificity of the lateral flow test kit.
Proviris Solutions will continue to provide updates as soon as they become available.